33C.F INNOCARE PHARMA LTD

- EUR
Market cap
-
P/E
-
P/B
2.42x
ROE
8.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 33C.F undervalued?

Graham number

The Graham number of INNOCARE PHARMA LTD cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

INNOCARE PHARMA LTD fundamental analysis

No fundamental analysis for INNOCARE PHARMA LTD yet.

INNOCARE PHARMA LTD stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.